Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)
Status:
Suspended
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure levels of blood and brain chemicals related to
oxidative stress and inflammation in healthy volunteers and individuals with Type 1 Gaucher
disease (GD1) to see if these levels are altered by GD1.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute
Collaborators:
Lysosomal Disease Network National Center for Advancing Translational Science (NCATS) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute of Neurological Disorders and Stroke (NINDS) Rare Diseases Clinical Research Network